510(k) Report

FDA applicant

Medrad, Inc.

Indianola, PA105 decisions1976–201426 recalls

FDA records 105 decisions for Medrad, Inc. (Indianola, PA) from 1976 to 2014: 105 510(k) clearances. Most are in product codes DXT (Injector And Syringe, Angiographic) and MOS (Coil, Magnetic Resonance, Specialty). Its devices cite 78 predicates, 43 of them its own earlier devices. 26 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Medrad, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2014

2007: 22008: 32009: 12010: 12011: 42012: 22013: 22014: 1
2007high 4 (2011) · low 0 (2015)2026

2026 so far, outlined.

Recalls per year

1in 2026

2010: 22011: 22012: 22013: 12014: 12015: 32016: 22017: 12018: 32022: 12026 (partial year): 1
2007high 3 (2015) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Medrad, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medrad, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Medrad”

FDA records each applicant name separately; these may or may not be the same firm.